Portside Wealth Group’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Portside Wealth Group's LMAT Position: Q2 2026 in Review
Portside Wealth Group increased its LeMaitre Vascular (LMAT) stake by 1.4% in Q2 2026, buying an estimated $8.92K and bringing the position to 6,390 shares worth $613K. The position accounts for 0.07% of the portfolio, ranked #265.
Portside Wealth Group first reported a position in LMAT in Q3 2024 and has held it in 8 quarters since. The position peaked at $688K in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Portside Wealth Group held 6,390 shares of LeMaitre Vascular worth $613K as of Q2 2026.
- Portside Wealth Group bought 87 LeMaitre Vascular shares in Q2 2026, an estimated $8.92K.
- LeMaitre Vascular made up 0.07% of Portside Wealth Group's portfolio in Q2 2026, its #265 holding.
- Portside Wealth Group first reported a position in LeMaitre Vascular in Q3 2024 and has held it in 8 quarters since.
- Portside Wealth Group's LeMaitre Vascular position peaked at $688K in Q1 2026.
- 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.